Stay updated with breaking news from Research Update Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. P...
Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. The Acute Disease Qualit...
Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023
Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA RELEASE KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptoms KINFAST is actively...
Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA